BANK VONTOBEL/PUT/ROCHE GS/220/0.02/21.06.24 Share Price

Warrant

WROAWV

CH1274776496

Market Closed - Swiss Exchange 08:50:00 31/05/2024 pm IST
0.02 CHF -16.67% Intraday chart for BANK VONTOBEL/PUT/ROCHE GS/220/0.02/21.06.24
3 months-84.38%
6 months-85.92%
Date Price Change
31/24/31 0.02 -16.67%

Delayed Quote Swiss Exchange

Last update May 31, 2024 at 08:50 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying ROCHE HOLDING AG
IssuerLogo Issuer Vontobel Vontobel
WROAWV
ISINCH1274776496
Date issued 11/07/2023
Strike 220 CHF
Maturity 21/06/2024 (13 Days)
Parity 50 : 1
Emission price 0.09 CHF
Emission volume N/A
Settlement physique
Currency CHF

Technical Indicators

Highest since issue 0.22 CHF
Lowest since issue 0.02 CHF
Delta-0.08x
Omega 30.75
Premium9.56x
Gearing404.33x
Moneyness 0.9068
Difference Strike -22.6 CHF
Difference Strike %-10.27%
Spread 0.016 CHF
Spread %80.00%
Theoretical value 0.0120
Implied Volatility 35.95 %
Total Loss Probability 91.34 %
Intrinsic value 0.000000
Present value 0.0120
Break even 219.40 CHF
Theta-0.01x
Vega0x
Rho-0x

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
20
Last Close Price
242.6 CHF
Average target price
277.5 CHF
Spread / Average Target
+14.40%
Consensus
  1. Stock Market
  2. Warrants
  3. WROAWV Warrant